PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastroesophageal reflux disease |
| Symptom | C0004763|barrett\'s esophagus |
| Sentences | 9 |
| PubMedID- 21694467 | Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion. |
| PubMedID- 23504527 | barrett's esophagus, with gastroesophageal reflux disease and obesity as risk factors, predisposes to esophageal adenocarcinoma (eac). |
| PubMedID- 20946664 | Background: esophageal adenocarcinomas (eacs) arise due to gastroesophageal reflux, with barrett's esophagus (be) regarded as precancerous lesion. |
| PubMedID- 20931428 | Conclusions: patients with progressive systemic sclerosis have a higher tendency to the more severe forms and complications of gastroesophageal reflux disease including barrett's esophagus than in those without progressive systemic sclerosis. |
| PubMedID- 23663216 | The need for obstructive sleep apnea screening in barrett's esophagus patients with nocturnal gastroesophageal reflux symptoms should be further evaluated. |
| PubMedID- 26377193 | A newly identified susceptibility locus near foxp1 modifies the association of gastroesophageal reflux with barrett's esophagus. |
| PubMedID- 25632808 | Adiponectin may modify the risk of barrett's esophagus in patients with gastroesophageal reflux disease. |
| PubMedID- 21636532 | gastroesophageal reflux is associated with adenocarcinoma in barrett's esophagus, but the incidence of this tumor is rising, despite widespread use of acid-suppressing medications. |
| PubMedID- 26032153 | Control of acid and duodenogastroesophageal reflux (dger) in patients with barrett's esophagus. |
Page: 1